Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FBIO
FBIO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FBIO News
Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes
Jan 16 2026
NASDAQ.COM
FDA Approves ZYCUBO for Menkes Disease, Cyprium to Earn Up to $129M in Milestones
Jan 13 2026
stocktwits
Fortress Biotech (FBIO) Secures FDA Approval for ZYCUBO, First Treatment for Menkes Disease
Jan 13 2026
NASDAQ.COM
Fortress Biotech's Subsidiary Nears Key FDA Decision, Shares Rise 3%
Jan 13 2026
NASDAQ.COM
FibroBiologics (FBLG) Stock Rises 7.68%, Attracts Market Attention
Jan 13 2026
NASDAQ.COM
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
Fortress Biotech's CUTX-101 NDA Resubmission Accepted by FDA with Target Date of January 14, 2026
Dec 15 2025
Globenewswire
Fortress Biotech's CUTX-101 NDA Resubmission Accepted by FDA with Target Date of January 14, 2026
Dec 15 2025
Newsfilter
Journey Medical Corporation Presents Efficacy Data Analysis from Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial at the 2025 Fall Clinical Dermatology Conference
Oct 24 2025
Newsfilter
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Oct 23 2025
PRnewswire
Fortress Biotech and Subsidiary Urica Therapeutics Report First Patient Doses in Crystalys Therapeutics' Global Phase 3 Trials of Dotinurad for Gout Treatment
Oct 21 2025
Newsfilter
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Oct 08 2025
PRnewswire
Wednesday's Major Stock Market Highlights: Morning News Summary!
Oct 01 2025
TipRanks
What Caused Fortress Biotech Stock (FBIO) to Drop 30% Today?
Oct 01 2025
TipRanks
Fortress Biotech and Urica Therapeutics Reveal $205 Million Series A Funding for Crystalys Therapeutics
Oct 01 2025
Newsfilter
Fortress Biotech Shares Drop Following FDA Rejection of Rare Disease Treatment
Oct 01 2025
SeekingAlpha
Show More News
